FTC Launches Formal Investigation Into Immucor
The U.S. Federal Trade Commission has served Immucor Inc. with a formal civil investigative demand concerning a series of acquisitions the maker of blood-bank instruments made in the 1990s....To view the full article, register now.
Already a subscriber? Click here to view full article